Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 1997

View Archived Issues

Vitamin E for maternal diabetes-associated malformations in offspring

In vitro profile of new quinolone: HSR-903

Second-generation NNRTI under development by Hoechst/Bayer

Abbott describes SAR leading to prokinetic motilides

SKB describes development of 5-HT4 antagonists for IBS

New antiarthritic agent from Czech research institute characterized

Gene Logic and P&G alliance for heart failure drug discovery

Pharmacokinetics of DW-116, ciprofloxacin and rufloxacin compared in animals

Roche seeks FDA approval for humanized antibody

Valaciclovir has comparable efficacy and safety to aciclovir in recurrent genital herpes

BMS-180048 vs. placebo for acute treatment of migraine

Vertex and Lilly join forces in hepatitis C drug development

Boston Life Sciences receives notice of patent allowance for CNS growth factor

Friedreich's ataxia: possible cause and potential treatments

Amersham and P&U form new company

ID Vaccine and the University of British Columbia collaborate on bacterial vaccines

Cellegy discovers compounds that modulate topical inflammatory and allergic responses

Natural remedy for the common cold evaluated in controlled clinical trial

AEterna's IND for Neoretna approved in Canada

NYU grants Medco option to license adenosine A2 agonists

Botulinum toxin type A evaluated in cerebral palsy

Gensia Sicor's GenESA System assigned new indication

Positive results reported for clot imaging agent MH-1

Glaxo Wellcome acquires Spectra Biomedical

U.S. notice of patent allowance for troponin I

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...